PERTZYE (Digestive Care, Inc.)
Welcome to the PulseAid listing for the PERTZYE drug offered from Digestive Care, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Digestive Care, Inc. |
| NON-PROPRIETARY NAME: | pancrelipase |
| SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-10-06 |
| END MARKETING DATE: | 0000-00-00 |
PERTZYE HUMAN PRESCRIPTION DRUG Details:
| Item Description | PERTZYE from Digestive Care, Inc. |
| LABELER NAME: | Digestive Care, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4000; 15125; 14375([USP’U]/1; [USP’U]/1; [USP’U]/1) |
| START MARKETING DATE: | 2016-10-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59767-004_5514b35a-081c-740f-e054-00144ff8d46c |
| PRODUCT NDC: | 59767-004 |
| APPLICATION NUMBER: | NDA022175 |
Other PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE Pharmaceutical Manufacturers / Labelers:
